Rheumatoid Arthritis vs. Ankylosing Spondylitis
Title: Rheumatoid Arthritis vs. Ankylosing SpondylitisCategory: Diseases and ConditionsCreated: 3/4/2022 12:00:00 AMLast Editorial Review: 3/4/2022 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - March 4, 2022 Category: Rheumatology Source Type: news
NaF-PET scans reveal plaque -- and possible risk of stroke
PET/CT scans can show plaque development in atherosclerosis patients and ma...Read more on AuntMinnie.comRelated Reading:
CAC scores predict cardiac risk in patients with high cholesterol
PET/MRI proves TNF blockers effective for ankylosing spondylitis
CT angio offers late thrombectomy option to stroke patients
CCTA plaque data improve heart disease risk assessment in diabetics
Delayed NaF-PET enhances coronary plaque detection (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 24, 2022 Category: Radiology Source Type: news
A Newly Published Network Meta-Analysis (NMA) Found TREMFYA ® (guselkumab) Ranked Highest for Overall Level of Skin Clearance and Provided Positive Joint Efficacy Among Active Psoriatic Arthritis (PsA) Therapies
Conclusions (i.e., comparable) are based on an overlap of pairwise 95 percent credible intervals.1c. PASI 90 is defined as at least 90 percent improvement from baseline in the PASI score. The PASI score grades the amount of surface area on each body region that is covered by PsO plaques and the severity of plaques for their redness, thickness, and scaliness.13 PASI 90 was not a controlled endpoint in DISCOVER-1 or -2.8,9d. TREMFYA q4w dosing is not currently FDA-approved.2e. The PsA-modified vdH-S score combines erosion and joint space narrowing scores derived from radiographs of joints in body regions impacted by PsA.14 T...
Source: Johnson and Johnson - January 26, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
Tofacitinib Approved for New Ankylosing Spondylitis Indication Tofacitinib Approved for New Ankylosing Spondylitis Indication
The action makes the drug the first Janus kinase (JAK) inhibitor to be approved for ankylosing spondylitis.FDA Approvals (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - December 16, 2021 Category: Rheumatology Tags: Rheumatology News Alert Source Type: news
U.S. FDA Approves Pfizer ’s Xeljanz (tofacitinib) for the Treatment of Active Ankylosing Spondylitis
NEW YORK--(BUSINESS WIRE) December 14, 2021 -- Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for Xeljanz® / Xeljanz® XR (tofacitinib) for... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - December 14, 2021 Category: Drugs & Pharmacology Source Type: news
Malignancy Risk in Patients With Secukinumab-treated Psoriasis Malignancy Risk in Patients With Secukinumab-treated Psoriasis
Does treatment with secukinumab increase the risk of malignancy in patients being treated for psoriasis, psoriatic arthritis, or ankylosing spondylitis?The British Journal of Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 14, 2021 Category: Consumer Health News Tags: Dermatology Journal Article Source Type: news
PET/MRI can improve diagnosis of peritoneal cancer
PET/MRI performs better than standard imaging for diagnosing cancer that ha...Read more on AuntMinnie.comRelated Reading:
PET/MRI proves TNF blockers effective for ankylosing spondylitis
PET/MRI proves valuable in difficult epilepsy cases
How can the clinical potential of PET/MRI be unlocked?
PET/MRI bests MRI alone for detecting recurrent prostate cancer
When will PET/MRI live up to its promise? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 10, 2021 Category: Radiology Source Type: news
PET diagnoses prosthetic joint infection
A new carbon-11-based PET radiotracer can help diagnose infection in patient...Read more on AuntMinnie.comRelated Reading:
PET/MRI proves TNF blockers effective for ankylosing spondylitis
Combining radiomics, AI with PET/MRI helps assess nodal status
PET/MRI proves valuable in difficult epilepsy cases
PET/MRI shows prowess for nodal staging in breast cancer
PET/MRI reveals blood clots in patients with AFib (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 7, 2021 Category: Radiology Source Type: news
PET/MRI proves TNF blockers effective for ankylosing spondylitis
PET/MRI scans of ankylosing spondylitis patients show that tumor necrosis facto...Read more on AuntMinnie.comRelated Reading:
PET/MRI proves valuable in difficult epilepsy cases
How can the clinical potential of PET/MRI be unlocked?
PET/MRI reveals blood clots in patients with AFib
PET/MRI bests MRI alone for detecting recurrent prostate cancer
PET tracer shows promise for diagnosing breast cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 3, 2021 Category: Radiology Source Type: news
New Analyses Suggest Favorable Results for STELARA ® (ustekinumab) When Used as a First-Line Therapy for Bio-Naïve Patients with Moderately to Severely Active Crohn’s Disease and Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, October 25, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from two new analyses of STELARA® (ustekinumab) for the treatment of adults with moderately to severely active Crohn’s disease (CD) and ulcerative colitis (UC).1,2 In a modelled analysisa focused on treatment sequencing using data from randomized controlled trials, network meta-analysis and literature, results showed patient time spent in clinical remission or response was highest when STELARA was used as a first-line advanced therapy for bio-naïve patients with moderately to severely acti...
Source: Johnson and Johnson - October 25, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
Arthritis: Best anti-inflammatory beverage to provide effective pain relief for joints
INFLAMMATORY arthritis is characterised by painful, swollen and tender joints. Common forms include: rheumatoid arthritis , psoriatic arthritis , systemic lupus erythematosus , gout and ankylosing spondylitis . (Source: Daily Express - Health)
Source: Daily Express - Health - October 8, 2021 Category: Consumer Health News Source Type: news
Consumer Health: What do you know about rheumatic diseases?
September is Rheumatic Disease Awareness Month, which makes this a good time to learn about four common rheumatic diseases: ankylosing spondylitis, gout, juvenile idiopathic arthritis and lupus. Ankylosing spondylitis Ankylosing spondylitis is an inflammatory disease that can cause some of the small bones in your spine to fuse. This fusing makes the spine less flexible and can result in a hunched-forward posture. If ribs are affected, it can be difficult to breathe deeply. Ankylosing spondylitis… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 20, 2021 Category: Databases & Libraries Source Type: news
No Gender Gap Seen in Ankylosing Spondylitis Prevalence No Gender Gap Seen in Ankylosing Spondylitis Prevalence
Report challenges conventional wisdom that males are more likely to develop ankylosing spondylitis.Medscape Medical News (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - September 8, 2021 Category: Orthopaedics Tags: Rheumatology News Source Type: news
What Aggravates Ankylosing Spondylitis?
Title: What Aggravates Ankylosing Spondylitis?Category: Diseases and ConditionsCreated: 7/22/2021 12:00:00 AMLast Editorial Review: 7/22/2021 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - July 22, 2021 Category: Rheumatology Source Type: news
Can You Live Long with Ankylosing Spondylitis
Can You Live a Long Life with Ankylosing Spondylitis? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - July 22, 2021 Category: General Medicine Source Type: news
